2023-05-22 11:43:11
Ironwood Pharmaceuticals Inc :
* IRONWOOD ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE VECTIVBIO, A CLINICAL-STAGE BIOTECHNOLOGY COMPANY PIONEERING NEW TREATMENTS FOR RARE AND SEVERE GASTROINTESTINAL DISEASES.
* IRONWOOD PHARMACEUTICALS INC. – IRONWOOD MAKES A CASH TENDER OFFER TO ACQUIRE ALL OF THE OUTSTANDING SHARES OF VECTIVBIO AT A PRICE OF $17.00 PER SHARE.
* IRONWOOD PHARMACEUTICALS INC – PROPOSED TRANSACTION FOR APPROXIMATELY $1 BILLION, NET OF VECTIVBIO’S CASH AND DEBT
* IRONWOOD PHARMACEUTICALS INC. PLANS TO FINANCE THE ACQUISITION WITH AVAILABLE CASH AND FUNDS FROM A FOUR-YEAR $500 MILLION REVOLVING CREDIT FACILITY.
* IRONWOOD PHARMACEUTICALS INC – ACQUISITION EXPECTED TO BE ACTIVE ON EARNINGS PER SHARE FROM 2026 Source text for Eikon: More company information:
1684757011
#Ironwood #Pharma #Acquire #VectivBio #Billion
